# Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma

> **NCT05643391** · NA · COMPLETED · sponsor: **Erasme University Hospital** · enrollment: 20 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** Radioembolization using Holmium-166

## Key facts

- **NCT ID:** NCT05643391
- **Lead sponsor:** Erasme University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2022-06-10
- **Final completion:** 2022-12-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05643391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05643391, "Safety and Feasibility of Radioembolization Using Ho-166 in Patients With Unresectable Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05643391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*